Key Highlights
- Roman Haehn appointed as Chief Commercial Officer at Mission Bio.
- Over 25 years of experience in diagnostics and life sciences research.
- Previously led significant growth at Agena Bioscience, Luminex Corporation, and Ventana Medical Systems.
- Will lead Global Marketing, Commercial teams, Business Development, and more at Mission Bio.
- Mission Bio’s Tapestri Platform pivotal in precision medicine and personalized therapies.
Source: Business Wire
Notable Quotes
- “Roman’s expertise and vision will be tremendous assets as Mission Bio looks to expand upon its leadership position in advancing single-cell multiomics within both research and clinical settings.” — Brian Kim, Chief Executive Officer at Mission Bio
- “The Tapestri Platform is an unparalleled technology in precision medicine. I look forward to working across the entire organization to expand our commercial capabilities.” — Roman Haehn, Chief Commercial Officer at Mission Bio
SoHC's Take
The appointment of Roman Haehn as Chief Commercial Officer is a strategic move by Mission Bio, reinforcing its commitment to expanding its leadership in single-cell multiomics solutions for precision medicine. Haehn’s extensive background in diagnostics and life sciences, highlighted by his successful tenure at Agena Bioscience, positions him well to drive Mission Bio’s commercial and growth strategies. His proven track record of increasing revenues and fostering innovation will be instrumental as Mission Bio continues to leverage its Tapestri Platform, which is setting new standards in personalized medicine and targeted therapies. This leadership enhancement underscores Mission Bio’s dedication to advancing precision medicine and improving patient health outcomes on a global scale.
